Cargando…
Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial
BACKGROUND: Tiludronate and clodronate are FDA-approved bisphosphonate drug therapies for navicular disease in horses. Although clinical studies have determined their ability to reduce lameness associated with skeletal disorders in horses, data regarding the effect on bone structure and remodeling i...
Autores principales: | Richbourg, Heather A., Mitchell, Colin F., Gillett, Ashley N., McNulty, Margaret A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859757/ https://www.ncbi.nlm.nih.gov/pubmed/29554967 http://dx.doi.org/10.1186/s12917-018-1423-2 |
Ejemplares similares
-
Tiludronate concentrations and cytologic findings in synovial fluid after intravenous regional limb perfusion with tiludronate in horses
por: Hunter, Barbara G., et al.
Publicado: (2015) -
The stunning clodronate
por: Mass, Elvira
Publicado: (2023) -
Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model
por: Moreau, Maxim, et al.
Publicado: (2011) -
Treatment of malignant hypercalcaemia with clodronate.
por: Percival, R. C., et al.
Publicado: (1985) -
Indirect osteoblast differentiation by liposomal clodronate
por: Okada, Emi, et al.
Publicado: (2017)